Supplementary Figure S3 from The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

Supplementary Figure S3 details the antitumor effects and gene set enrichment analysis data associated with coadministration of MRTX0902 and adagrasib in KRAS G12C-mutant human tumor xenograft models.